Migraine is a debilitating neurological disorder afflicting over 39 million people in the U.S. and approximately 1 billion people worldwide. As the leading cause of disability among all neurologic conditions, migraine headaches significantly diminish patient quality of life while placing tremendous health care burdens on society.
Rethinking Migraine explores the latest avenues of patient assessment, communication, and care for this disorder. From recognizing the severe impact of episodic migraines, to learning new insights about disease pathophysiology, to determining best practices for acute and preventive therapies, this series provides critical strategies and tools for migraine management.
This non-certified educational series is sponsored by Lilly. Content for this series is produced and controlled by ReachMD. This series is intended for healthcare professionals only.